New combo therapy aims to save voices, fight tough cancer
NCT ID NCT07310771
Summary
This study is testing a new combination of three cancer drugs (sintilimab, nimotuzumab, and chemotherapy) followed by radiation for people with advanced head and neck cancer that has not spread to distant parts of the body. The main goal is to see if this approach can effectively control the cancer while preserving the patient's voice box (larynx). It will measure how well the treatment works and monitor its safety in a small group of 23 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-SCCHN) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.